Removal‐Free and Multicellular Suspension Bath‐Based 3D Bioprinting
Advanced Materials · 2024-11 · 36 (48)
DOI: 10.1002/adma.202406891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 12.10.2024. Verfasst von Shuai Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. Hauptthemen laut MEDLINE: Bioprinting, Printing, Three-Dimensional, Hydrogels, Tissue Engineering. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Jiao Tong University School of Medicine, School of Medicine, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Suspension bath‐based 3D bioprinting (SUB3BP) is effective in creating engineered vascular structures. The transfer of oxygen and nutrients via engineered vascular networks is necessary for tissue or organ survival and integration following transplantation. Existing SUB3BP techniques face challenges in fabricating hierarchical structures with multicellular organization, including issues related to suspension bath removal, restricted material choices, and low accuracy. A next‐generation SUB3BP technique that is removal‐free and multicellular is presented. A simple, storable, stable, and scalable starch hydrogel design leverages the diverse spectrum of hydrogels available for use in SUB3BP. Starch granules (8.1 µm) create vascular structures with minimal surface roughness (2.5 µm) that simulate more natural vessel walls compared to prior research. The development of cells and organoids, as well as the bioprinting of multicellular skin models with vasculature, demonstrates that starch suspension baths eliminate the removal process and have the potential for fabricating artificial tissue with a hierarchical structure and multicellular distribution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
- Zhejiang Key Laboratory of Precision Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
- Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
- Key Laboratory of Advanced Technologies of Materials (MOE), School of Materials Science and Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, China.
- Department of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
- Clinical and Translational Research Center for 3D Printing Technology, Medical 3D Printing Innovation Research Center, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011…
Förderung
- National Natural Science Foundation of China
- Shanghai Jiao Tong University School of Medicine
- School of Medicine, Shanghai Jiao Tong University
Zitieren
APA
Li, S., Li, J., Xu, J., Shen, Y., Shang, X., Li, H., Wang, J., Liu, Y., Qiang, L., Qiao, Z., Wang, J., He, Y., & Hu, Y. (2024). Removal‐Free and Multicellular Suspension Bath‐Based 3D Bioprinting. Advanced Materials, 36(48). https://doi.org/10.1002/adma.202406891
Vancouver
Li S, Li J, Xu J, Shen Y, Shang X, Li H, et al. Removal‐Free and Multicellular Suspension Bath‐Based 3D Bioprinting. Advanced Materials. 2024;36(48). doi:10.1002/adma.202406891
BibTeX
@article{Li2024,
author = {Li, Shuai and Li, Jianping and Xu, Jian and Shen, Yifan and Shang, Xiushuai and Li, Hangyu and Wang, Jingwen and Liu, Yihao and Qiang, Lei and Qiao, Zhiguang and Wang, Jinwu and He, Yong and Hu, Yihe},
title = {Removal‐Free and Multicellular Suspension Bath‐Based 3D Bioprinting},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {48},
doi = {10.1002/adma.202406891}
}
EUVIMED